Compare A O Smith Corp (AOS) vs BridgeBio Pharma Inc (BBIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
A O Smith Corp vs BridgeBio Pharma Inc — how do they compare? A O Smith Corp trades at $63.65 (market cap $8.65B), while BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B). The key difference: BridgeBio Pharma Inc is the larger of the two by market cap, and A O Smith Corp pays a 2.26% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| AOS | BBIO | |
|---|---|---|
Market Cap | $8.65B | $16.36B |
Sector | Industrials | Health |
52-Week High | $80.47 | $90.17 |
52-Week Low | $55.78 | $47.29 |
Enterprise Value | $9.15B | $18.14B |
Dividend Yield | 2.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About A O Smith Corp
A.O. Smith Corporation manufactures and markets comprehensive lines of residential and commercial gas, gas tankless, and electric water heaters. Supplementary products include water heating equipment, condensing and noncondensing boilers, and water system tanks. The company's two operating segments are by geographic region: North America (majority of total revenue) and the Rest of the World. A material portion of sales in North America derive from replacing existing products, and the company utilizes a wholesale distribution channel and multiple selling locations. The Rest of the World segment sells primarily to Asian countries and operates sales offices to expand distribution and market its product portfolio.
Read more on AOS →About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →
